SUBSCRIBE
SUBSCRIBE
News   FDA

Teva Pharmaceutical Industries Limited Announces Approval and Launch of Generic Valtrex(R)

May 25, 2010 | 
1 min read
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) today announced U.S. Food and Drug Administration (FDA) approval and commercial launch of its generic version of GlaxoSmithKline’s antiviral product, Valtrex® (valacyclovir hydrochloride) Tablets 500 mg and 1 g.
FDA Approvals Asia
MORE ON THIS TOPIC
Contemporary art collage showing a hand giving a thumbs down surrounded by red arrows pointing down, concept of negative feedback and bad review
Complete response letters
Capricor Plunges on FDA Rejection of DMD Cell Therapy
July 11, 2025
 · 
3 min read
 · 
Tristan Manalac
Cambridge, USA - 16 August 2024. View of Moderna office entrance with logo sign, Biotechnology industry
COVID-19
Moderna Wins Full Approval for COVID-19 Shot for Higher-Risk Kids
July 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Person buried in paperwork hand raised collage art. Man drown in work concept. Overwork illustration for news banner, web articles, and posters
FDA
FDA Rejections: We Read 200 CRLs So You Don’t Have To
July 11, 2025
 · 
5 min read
 · 
Annalee Armstrong
Complete response letters
FDA Publishes Cache of Complete Response Letters in Bid for ‘Radical Transparency’
July 10, 2025
 · 
2 min read
 · 
Dan Samorodnitsky